HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypoxia as a therapy for mitochondrial disease.

Abstract
Defects in the mitochondrial respiratory chain (RC) underlie a spectrum of human conditions, ranging from devastating inborn errors of metabolism to aging. We performed a genome-wide Cas9-mediated screen to identify factors that are protective during RC inhibition. Our results highlight the hypoxia response, an endogenous program evolved to adapt to limited oxygen availability. Genetic or small-molecule activation of the hypoxia response is protective against mitochondrial toxicity in cultured cells and zebrafish models. Chronic hypoxia leads to a marked improvement in survival, body weight, body temperature, behavior, neuropathology, and disease biomarkers in a genetic mouse model of Leigh syndrome, the most common pediatric manifestation of mitochondrial disease. Further preclinical studies are required to assess whether hypoxic exposure can be developed into a safe and effective treatment for human diseases associated with mitochondrial dysfunction.
AuthorsIsha H Jain, Luca Zazzeron, Rahul Goli, Kristen Alexa, Stephanie Schatzman-Bone, Harveen Dhillon, Olga Goldberger, Jun Peng, Ophir Shalem, Neville E Sanjana, Feng Zhang, Wolfram Goessling, Warren M Zapol, Vamsi K Mootha
JournalScience (New York, N.Y.) (Science) Vol. 352 Issue 6281 Pg. 54-61 (Apr 01 2016) ISSN: 1095-9203 [Electronic] United States
PMID26917594 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2016, American Association for the Advancement of Science.
Chemical References
  • Bacterial Proteins
  • Biomarkers
  • Hypoxia-Inducible Factor 1
  • Isoquinolines
  • Ndufs4 protein, mouse
  • antimycin
  • Antimycin A
  • Von Hippel-Lindau Tumor Suppressor Protein
  • CRISPR-Associated Protein 9
  • Cas9 endonuclease Streptococcus pyogenes
  • Endonucleases
  • Electron Transport Complex I
  • Oxygen
  • Glycine
  • roxadustat
Topics
  • Anaerobiosis
  • Animals
  • Antimycin A (analogs & derivatives, pharmacology)
  • Bacterial Proteins
  • Biomarkers (blood)
  • Body Temperature
  • Body Weight
  • CRISPR-Associated Protein 9
  • Disease Models, Animal
  • Electron Transport (drug effects)
  • Electron Transport Complex I (genetics)
  • Endonucleases
  • Energy Metabolism (drug effects, genetics)
  • Gene Knockout Techniques
  • Genome-Wide Association Study
  • Glycine (analogs & derivatives, pharmacology, therapeutic use)
  • Humans
  • Hypoxia-Inducible Factor 1 (metabolism)
  • Isoquinolines (pharmacology, therapeutic use)
  • K562 Cells
  • Leigh Disease (genetics, pathology, therapy)
  • Mice
  • Mice, Knockout
  • Mitochondria (drug effects, metabolism)
  • Oxygen (metabolism)
  • Respiration
  • Suppression, Genetic
  • Von Hippel-Lindau Tumor Suppressor Protein (antagonists & inhibitors, genetics)
  • Zebrafish

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: